Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling

Betulinic acid, a natural compound with potent anticancer effects

(2010) Franziska B. Mullauer et al.   ANTI-CANCER DRUGS

Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice

(2010) N. Xia et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Resveratrol: A Multifunctional Compound Improving Endothelial Function

(2009) Huige Li et al.   CARDIOVASCULAR DRUGS AND THERAPY

Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System

(2009) Huige Li et al.   CURRENT PHARMACEUTICAL DESIGN

Resveratrol bioavailability and toxicity in humans

(2009) Charles-Henry Cottart et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Pentacyclic Triterpene Distribution in Various Plants – Rich Sources for a New Group of Multi-Potent Plant Extracts

(2009) Sebastian Jäger et al.   MOLECULES

Molecular mechanisms underlying the activation of eNOS

(2009) Ingrid Fleming   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase Enhancer AVE9488 After Experimental Myocardial Infarction

(2008) Daniela Fraccarollo et al.   CIRCULATION

Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells

(2008) Carolyn M. Klinge et al.   FASEB JOURNAL

Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic Changes

(2008) Toshio Imanishi et al.   HYPERTENSION

Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression

(2008) Jürg Nussberger et al.   HYPERTENSION

Addition of Eplerenone to an Angiotensin-Converting Enzyme Inhibitor Effectively Improves Nitric Oxide Bioavailability

(2008) Toshio Imanishi et al.   HYPERTENSION

More NO-No More ROS

(2008) Johann Bauersachs et al.   HYPERTENSION

Aliskiren Improves Nitric Oxide Bioavailability and Limits Atherosclerosis

(2008) Subodh Verma et al.   HYPERTENSION

Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling

(2008) P. Wohlfart et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy

(2008) M. Satoh et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies

(2008) Ulrich Förstermann   Nature clinical practice. Cardiovascular medicine

Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus

(2007) Philip Wenzel et al.   ATHEROSCLEROSIS